Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

McKesson Stock Price And Research (NYSE: MCK): Strong Buy

Published 05/09/2018, 01:06 AM
Updated 05/14/2017, 06:45 AM

McKesson (NYSE:MCK) is a large cap company that operates within the health care providers and services industry. Its market cap is $30 billion today and the total one-year return is 2.87% for shareholders.

McKesson stock is underperforming the market. It's beaten down, but it reports earnings soon. So is it a good time to buy? To answer this question, we've turned to the Investment U Stock Grader. Our research team built this system to diagnose the financial health of a company.

Our system looks at six key metrics:

Earnings-per-Share (EPS) Growth: McKesson reported a recent EPS growth rate of 50.17%. That's above the health care providers and services industry average of 21.85%. That's a great sign. McKesson's earnings growth is outpacing competitors.

Price-to-Earnings (P/E): The average price-to-earnings ratio of the health care providers and services industry is 33.17. And McKesson's ratio comes in at 18.45. It's trading at a better value than many of its competitors.

Debt-to-Equity : The debt-to-equity ratio for McKesson stock is 65.59%. That's below the health care providers and services industry average of 67.17%. That's a good sign. McKesson's debt levels are not out of control.

Free Cash Flow per Share Growth : McKesson has decreased its FCF per share over the last year relative to its competitors. That's not good for investors. In general, if a company is growing its FCF, it will be able to pay down debt, buy back stock, pay out more in dividends and/or invest money back into the business to help boost growth.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Profit Margins : The profit margin of McKesson comes in at 1.68% today. And generally, the higher, the better. We also like to see this ratio above competitors. McKesson's profit margin is above the health care providers and services average of -2.93%. So that's a positive indicator for investors.

Return on Equity : Return on equity gives us a look at the amount of net income returned to shareholders. The ROE for McKesson is 49.43% and that's above the industry average ROE of 13.13%.

McKesson stock passes five of our six key metrics today. That's why our Investment U Stock Grader gives it a Strong Buy.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.